People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Velo Holdings Ltd | — | Other | Series A | $23.9M | $180.3M | 2017 |
| Gemina Laboratories Ltd. | — | Biotechnology | Pre-Seed | $673K | $1.7M | 2022 |
John Davies at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Davies on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| ROBERT GREENE | 1 | 9 |
| MICHAEL LIGGETT | 1 | 5 |
| Martin Cronin | 1 | 3 |
| Joseph Saunders | 1 | 3 |
| Andrew Weinstein | 1 | 2 |
| John Partridge | 1 | 2 |
| James Tansey | 1 | 1 |
| Mike Liggett | 1 | 1 |
| Elliott DeLoach | 1 | 1 |
| Rob Greene | 1 | 1 |
| Martha Najib | 1 | 1 |
| Brian Firth | 1 | 1 |
| Bola Grace | 1 | 1 |
| Davis Rokoss | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.